N-MOmentum

AstraZeneca Spinoff Viela Bio Reports Positive Phase IIb Trial in Rare Disease
BioSpace
Thu, 01/3/19 - 04:13 pm
Viela Bio
AstraZenecal
N-MOmentum
inebilizumab
NMOSD